Synergistic strategies for enhanced liver cancer therapy with sorafenib/resveratrol PEGylated liposomes in vitro and in vivo-Reference-Cited by-同舟云学术

Synergistic strategies for enhanced liver cancer therapy with sorafenib/resveratrol PEGylated liposomes in vitro and in vivo

Published:2024-06 Issue: Volume:96 Page:105703
ISSN:1773-2247
Container-title:Journal of Drug Delivery Science and Technology
language:en
Short-container-title:Journal of Drug Delivery Science and Technology

Author:

Alrashidi Amal Abdullah^ORCID,Alavi Seyed Zeinab,Koohi Maedeh^ORCID,Raza Aun^ORCID,Almutairy Bandar,Alharthi Sitah^ORCID,Ebrahimi Shahmabadi Hasan^ORCID,Alavi Seyed Ebrahim^ORCID

Funder

Shaqra University

Rafsanjan University of Medical Sciences

Princess Nourah bint Abdulrahman University

Publisher

Elsevier BV

Reference66 articles.

1. Continuous improvements in short and long-term outcomes after partial hepatectomy for hepatocellular carcinoma in the 21st century: single institution experience with 1300 resections over 18 years;Goh;Surgical Oncology,2021

2. Centromere protein F (CENPF) serves as a potential prognostic biomarker and target for human hepatocellular carcinoma;Huang;J. Cancer,2021

3. Understanding sorafenib-induced ferroptosis and resistance mechanisms: implications for cancer therapy;Li;Eur. J. Pharmacol.,2023

4. LY3214996 relieves acquired resistance to sorafenib in hepatocellular carcinoma cells;Ma;Int. J. Med. Sci.,2021

5. The role of IGF/IGF-1R signaling in hepatocellular carcinomas: stemness-related properties and drug resistance;Ngo;Int. J. Mol. Sci.,2021

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in encapsulation of resveratrol for enhanced delivery;Food Chemistry;2024-12

2. Bile salt integrated cerasomes: A potential nanocarrier for enhancement of the oral bioavailability of idarubicin hydrochloride;International Journal of Pharmaceutics;2024-09

3. Nanoparticle-integrated metal–organic frameworks: a revolution in next-generation drug delivery systems;Journal of Pharmaceutical Investigation;2024-08-02

4. Developing Engineered Nano-Immunopotentiators for the Stimulation of Dendritic Cells and Inhibition and Prevention of Melanoma;Pharmaceutical Research;2024-06